ALDH7A1 and neoplasm: Underlying this method is that Tan IIA at least partly targets at ALDH7A1 and inhibits its enzymatic activity, decreasing the intracellular level of NADH and the osmolytic products, betaine, glycerate, etc., which further interfere with glycolysis, breaks the osmotic balance, and result in tumor growth arrest and/or cell apoptosis.